Publication date: Sep 03, 2019
This post was originally published on this site People at a pre-symptomatic, or premanifest, stage of Huntington’s disease (HD) have subtle speech alterations that may be used as a marker to evaluate new therapies intended to stop or slow disease progression before it becomes too debilitating. The study with that recent research, -Speech in prodromal and symptomatic Huntington’s disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases,” was published in the journal Neuroscience & Biobehavioral Reviews. However, pinpointing the specific speech marks that distinguish people with premanifest HD from healthy individuals remains unclear, in part due to the lack of neuroimaging studies that could help draw a link between speech changes and brain degeneration. -Stronger evidence is needed to establish the sensitivity and reliability of speech markers in detecting pathophysiological changes in [premanifest] HD and evaluating the effectiveness of pharmacological therapy,” the researchers wrote. The post Subtle Changes in Speech Mark Pre-symptomatic Huntington’s, Study Finds appeared first on Huntington’s Disease News. The post Subtle Changes in Speech Mark Pre-symptomatic Huntington’s, Study Finds appeared first on BioNewsFeeds.
- Speech in prodromal and symptomatic Huntington’s disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases.
- Huntington’s Disease Explained
- Differential Changes in Functional Connectivity of Striatum-Prefrontal and Striatum-Motor Circuits in Premanifest Huntington’s Disease.
- Huntington’s Disease: Stem Cell Hope for Huntington’s Disease
- Huntington’s Patients Have Difficulty Recognizing Mental States of Others, Study Reveals